OVID THERAPEUTICS INC. - COMMON STOCK

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

04 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results

08 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

28 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

06 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

01 дек 2023 06:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates

03 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026

18 окт 2023 07:00:01 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

10 окт 2023 07:00:01 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023

26 сен 2023 06:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

20 сен 2023 06:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Participate in Upcoming September Investor Conferences

30 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates

04 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023

01 авг 2023 07:00:01 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer

28 июн 2023 07:00:01 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Added to Russell 3000® Index

26 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates

05 май 2023 06:30:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors

01 май 2023 05:00:00 Источник Nasdaq GlobeNewswire

Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology Annual Meeting

27 апр 2023 13:30:14 Источник Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

10 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results

13 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire